Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Authors:

Abstract
Background Chimeric antigen receptor (CAR)-T cell therapy is a promising immunotherapy for various hematologic malignancies. Whereas acute toxicities, such as c